Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003883 · ClinicalTrials.gov registry record · Phase 3
Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation
A Phase 3 study, sponsored by Fred Hutchinson Cancer Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 578
- Enrollment target
NCT00003883 is a Phase 3 study that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 578 participants.
The verdict
NCT00003883, a Phase 3 study, has completed, sponsored by Fred Hutchinson Cancer Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 578 participants
- Enrollment target
Study Summary
RATIONALE: Giving itraconazole or fluconazole may be effective in preventing infections in patients undergoing peripheral stem cell or bone marrow transplantation. It is not yet known whether itraconazole is more effective than fluconazole for preventing infections. PURPOSE: Randomized phase III trial to compare the effectiveness of itraconazole with fluconazole to prevent infections in patients undergoing peripheral stem cell or bone marrow transplantation.
Interventions
- DRUG itraconazole
- DRUG fluconazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 578 participants |
| Start Date | 1998-10 |
| Est. Completion | 2002-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00003883
The ClinicalTrials.gov registry entry for NCT00003883 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 578 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fred Hutchinson Cancer Center, which has 483 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which itraconazole is the first listed.
NCT00003883 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00003883 about?
NCT00003883 is a clinical study titled "Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation". RATIONALE: Giving itraconazole or fluconazole may be effective in preventing infections in patients undergoing peripheral stem cell or bone marrow transplantation. It is not yet known whether itraconazole is more effective than fluconazole for preventing infections. PURPOSE: Randomized phase III tr...
What is the current status of trial NCT00003883?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 578 participants. The study started on 1998-10. Estimated completion is 2002-07.
What interventions are being tested in trial NCT00003883?
The interventions under investigation include: itraconazole (DRUG), fluconazole (DRUG).
Who is sponsoring clinical trial NCT00003883?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.